UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000040984
Receipt No. R000046798
Scientific Title Questionnaire survey about information and support for patients with lung cancer, mesothelioma or thymic tumor
Date of disclosure of the study information 2020/07/03
Last modified on 2021/07/03 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Questionnaire survey about information and support for patients with lung cancer, mesothelioma or thymic tumor
Acronym Questionnaire survey about information and support for thoracic cancer patients
Scientific Title Questionnaire survey about information and support for patients with lung cancer, mesothelioma or thymic tumor
Scientific Title:Acronym Questionnaire survey about information and support for thoracic cancer patients
Region
Japan

Condition
Condition lung cancer, mesothelioma and thymic tumor
Classification by specialty
Pneumology Hematology and clinical oncology Surgery in general
Chest surgery Adult
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to investigate the degree of satisfaction with medical information obtained by patients.
We conduct a questionnaire survey of patients with lung cancer, mesothelioma, and thymic tumor. The questionnaire contains questions from researchers, EORTC QLQ C30 and INFO25.
Basic objectives2 Others
Basic objectives -Others The purpose is to improve the content and quality of medical information to be provided.
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Compare the degree of satisfaction with the medical information obtained between the purchase group and the non-purchase group of [Lung cancer guidebook for patients].
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) Patients diagnosed with lung cancer, malignant pleural mesothelioma, or thymic tumor (histopathological diagnosis is not essential)
2) Patients consent to this study registration
Key exclusion criteria Not applicable.
Target sample size 200

Research contact person
Name of lead principal investigator
1st name Sawa
Middle name
Last name Toshiyuki
Organization Gifu municipal Hospital
Division name Cancer center
Zip code 500-8513
Address 7-1, Kashima-cho,Gifu city, Gifu
TEL (058)251-1101
Email sawatoshiyuki@yahoo.co.jp

Public contact
Name of contact person
1st name Takayuki
Middle name
Last name Takahama
Organization Kindai University Nara Hospital
Division name Department of medical oncology
Zip code 6300293
Address 1248-1, Otoda, Ikoma city, Nara
TEL 0743-77-0880
Homepage URL
Email takahama_t@med.kindai.ac.jp

Sponsor
Institute The Japan lung cancer society
Institute
Department

Funding Source
Organization The Japan lung cancer society
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kindai University Nara Hospital
Address 1248-1, Otoda, Ikoma city, Nara
Tel 0743-77-0880
Email n-rinri@med.kindai.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 07 Month 03 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 332
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2020 Year 06 Month 29 Day
Date of IRB
2020 Year 06 Month 30 Day
Anticipated trial start date
2020 Year 07 Month 03 Day
Last follow-up date
2022 Year 07 Month 02 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Request QOL survey and input from researcher's questionnaire.

Management information
Registered date
2020 Year 07 Month 02 Day
Last modified on
2021 Year 07 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000046798